Atara Biotherapeutics (ATRA) Non-Current Assets (2013 - 2026)
Atara Biotherapeutics (ATRA) reported Non-Current Assets of $7.49 million for Q2 2026, down 38.2% from $12.13 million a year earlier and down 4.2% from the prior quarter.
Powered by 
Analysis
Atara Biotherapeutics (ATRA) Non-Current Assets (2013 - 2026) Analysis & Trends
At the end of FY2025, Atara Biotherapeutics posted Non-Current Assets of $8.02 million, down 81.9% from FY2024.
- Non-Current Assets has declined for four consecutive years, with a five-year compound annual growth rate of -34.2% (FY2020 to FY2025).
- By year, Non-Current Assets came in at $44.2 million in FY2024 (-30.5%), $63.64 million in FY2023 (-21.8%), $81.34 million in FY2022 (-2.6%) and $83.51 million in FY2021 (+28.8%).
- The Q2 2026 figure ranks as the lowest quarterly Non-Current Assets since Q1 2017.
- Year over year, Non-Current Assets has now declined in each of the last 15 quarters, with an average decline of 56.4% over the last eight quarters.
- The high point for year-over-year Non-Current Assets in five years was Q2 2022 (growth of 38.3%); the low point was Q4 2025 (a decline of 81.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $7.82 million (Q1 2026), $8.02 million (Q4 2025) and $11.74 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 141.07 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 159.77 Bn |
| 10 | Atara Biotherapeutics | 141.76 Mn | 131.86 Mn | 439,000.00 | 7.49 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.49 Mn |
| Mar 31, 2026 | 7.82 Mn |
| Dec 31, 2025 | 8.02 Mn |
| Sep 30, 2025 | 11.74 Mn |
| Jun 30, 2025 | 12.13 Mn |
| Mar 31, 2025 | 34.86 Mn |
| Dec 31, 2024 | 44.20 Mn |
| Sep 30, 2024 | 50.85 Mn |
| Jun 30, 2024 | 54.87 Mn |
| Mar 31, 2024 | 58.84 Mn |
| Dec 31, 2023 | 63.64 Mn |
| Sep 30, 2023 | 70.09 Mn |
| Jun 30, 2023 | 74.12 Mn |
| Mar 31, 2023 | 77.90 Mn |
| Dec 31, 2022 | 81.34 Mn |
| Sep 30, 2022 | 85.27 Mn |
| Jun 30, 2022 | 89.14 Mn |
| Mar 31, 2022 | 82.89 Mn |
| Dec 31, 2021 | 83.51 Mn |
| Sep 30, 2021 | 80.43 Mn |
API Access
Atara Biotherapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=ATRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "ATRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=ATRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();